Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Impact on Overactive Bladder Syndrome
NCT02524769Completed
- Sponsor
- Loyola University Chicago
- Start
- Dec 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of conjugated estrogens in overactive bladder (OAB), sponsored by Loyola University Chicago. Primary endpoint: Change in the Relative Abundance of Lactobacillus at 12 weeks. Started Dec 2015; status: completed.
02
Drugs
conjugated estrogens
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02524769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02524769.